Prudential Financial’s ChemoCentryx, Inc. CCXI Stock Holding History

Prudential Financial’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-289,810	Closed	-$7.18M	–	2758
2022 Q2	$7.18M	Buy	+289,810	New	+$6.39M	0.01%	769
2022 Q1	–	Sell	-73,505	Closed	-$2.68M	–	2722
2021 Q4	$2.68M	Buy	+73,505	New	+$2.58M	﹤0.01%	1373
2021 Q2	–	Sell	-4,025	Closed	-$206K	–	2638
2021 Q1	$206K	Sell	4,025 -29	-0.7%	-$1.75K	﹤0.01%	2400
2020 Q4	$251K	Sell	4,054 -580	-13%	-$33.2K	﹤0.01%	2296
2020 Q3	$254K	Buy	4,634 +1,064	+30%	+$57.3K	﹤0.01%	2220
2020 Q2	$205K	Buy	+3,570	New	+$194K	﹤0.01%	2256
2019 Q3	–	Sell	-16,360	Closed	-$152K	–	2499
2019 Q2	$152K	Sell	16,360 -5,680	-26%	-$65.8K	﹤0.01%	2371
2019 Q1	$306K	Buy	+22,040	New	+$252K	﹤0.01%	2203
2018 Q3	–	Sell	-10,380	Closed	-$137K	–	2481
2018 Q2	$137K	Buy	+10,380	New	+$124K	﹤0.01%	2379

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Prudential Financial's CCXI Position: Q3 2022 in Review

Prudential Financial sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 289,810 shares — an estimated $7.18M sold.

Prudential Financial first reported a position in CCXI in Q2 2018 and held it in 9 quarters. The position peaked at $7.18M in Q2 2022. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Prudential Financial reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Prudential Financial sold 289,810 ChemoCentryx, Inc. shares in Q3 2022, an estimated $7.18M.
Prudential Financial first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 9 quarters.
Prudential Financial's ChemoCentryx, Inc. position peaked at $7.18M in Q2 2022.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.